{"component": "clause", "props": {"groups": [{"snippet": "(a) Neither any Seller, nor any of its Affiliates, any of their respective directors, officers, managers or employees or, to Sellers\u2019 Knowledge, any of their other respective Representatives, in any way relating to the Purchased Assets or the Business: (i) has taken any action in violation of any applicable anticorruption Law, including the U.S. Foreign Corrupt Practices Act (\u201cFCPA\u201d) (15 U.S.C. \u00a7 78 dd-1 et seq.); or (ii) has corruptly, offered, paid, given, promised to pay or give, or authorized the payment or gift of anything of value, directly or indirectly, to any \u201cPublic Official\u201d, as defined in this Section 3.17, for purposes of (A) influencing any act or decision of any Public Official in his official capacity; (B) inducing such Public Official to do or omit to do any act in violation of his lawful duty; (C) securing any improper advantage; or (D) inducing such Public Official to use his or her influence with a government, Governmental Authority, or commercial enterprise owned or controlled by any Governmental Authority (including state-owned or controlled veterinary or medical facilities), in order to assist any Seller or any Affiliates of any Seller, related in any way to the Purchased Assets or the Business, in obtaining or retaining business.\n(b) No Seller\u2019s officers, directors, employees or agents acting on behalf of any Seller are themselves Public Officials.\n(c) For purposes of this Section 3.17, \u201cPublic Official\u201d means: (i) any officer, employee or representative of any regional, Federal, state, provincial, county or municipal government or government department, agency, or other division; (ii) any officer, employee or representative of any commercial enterprise that is owned or controlled by a government, including any state-owned or controlled veterinary or medical facility; (iii) any officer, employee or representative of any public international organization, such as the African Union, the International Monetary Fund, the United Nations or the World Bank; (iv) any person acting in an official capacity for any government or Governmental Authority, enterprise, or organization identified above; and (v) any official of a political party or candidate for political office.", "snippet_links": [{"key": "to-sellers", "type": "clause", "offset": [122, 132]}, {"key": "respective-representatives", "type": "definition", "offset": [164, 190]}, {"key": "relating-to", "type": "definition", "offset": [203, 214]}, {"key": "the-purchased-assets", "type": "definition", "offset": [215, 235]}, {"key": "the-business", "type": "clause", "offset": [239, 251]}, {"key": "any-action", "type": "definition", "offset": [267, 277]}, {"key": "in-violation", "type": "definition", "offset": [278, 290]}, {"key": "anticorruption-law", "type": "definition", "offset": [309, 327]}, {"key": "the-us", "type": "clause", "offset": [339, 346]}, {"key": "foreign-corrupt-practices-act", "type": "definition", "offset": [348, 377]}, {"key": "to-pay", "type": "clause", "offset": [472, 478]}, {"key": "the-payment", "type": "clause", "offset": [502, 513]}, {"key": "anything-of-value", "type": "clause", "offset": [525, 542]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [544, 566]}, {"key": "official-capacity", "type": "clause", "offset": [709, 726]}, {"key": "improper-advantage", "type": "definition", "offset": [840, 858]}, {"key": "commercial-enterprise", "type": "definition", "offset": [971, 992]}, {"key": "owned-or-controlled", "type": "definition", "offset": [993, 1012]}, {"key": "medical-facilities", "type": "clause", "offset": [1094, 1112]}, {"key": "to-assist", "type": "clause", "offset": [1124, 1133]}, {"key": "no-seller", "type": "clause", "offset": [1278, 1287]}, {"key": "on-behalf-of", "type": "clause", "offset": [1338, 1350]}, {"key": "public-officials", "type": "definition", "offset": [1377, 1393]}, {"key": "for-purposes-of-this-section", "type": "clause", "offset": [1399, 1427]}, {"key": "municipal-government", "type": "definition", "offset": [1558, 1578]}, {"key": "any-state", "type": "definition", "offset": [1761, 1770]}, {"key": "medical-facility", "type": "clause", "offset": [1805, 1821]}, {"key": "public-international-organization", "type": "definition", "offset": [1876, 1909]}, {"key": "african-union", "type": "definition", "offset": [1923, 1936]}, {"key": "international-monetary-fund", "type": "definition", "offset": [1942, 1969]}, {"key": "the-united-nations", "type": "clause", "offset": [1971, 1989]}, {"key": "the-world-bank", "type": "definition", "offset": [1993, 2007]}, {"key": "any-person", "type": "clause", "offset": [2014, 2024]}, {"key": "an-official", "type": "definition", "offset": [2035, 2046]}, {"key": "government-or-governmental-authority", "type": "definition", "offset": [2064, 2100]}, {"key": "any-official", "type": "clause", "offset": [2156, 2168]}, {"key": "political-party", "type": "definition", "offset": [2174, 2189]}, {"key": "political-office", "type": "clause", "offset": [2207, 2223]}], "samples": [{"hash": "6KJDjGr8OFh", "uri": "/contracts/6KJDjGr8OFh#anticorruption-matters", "label": "Asset Purchase Agreement (Avadel Pharmaceuticals PLC)", "score": 29.2026004791, "published": true}, {"hash": "lVr5YpubBiN", "uri": "/contracts/lVr5YpubBiN#anticorruption-matters", "label": "Asset Purchase Agreement (Cerecor Inc.)", "score": 27.3559207916, "published": true}, {"hash": "7Mxgjl982wQ", "uri": "/contracts/7Mxgjl982wQ#anticorruption-matters", "label": "Asset Purchase Agreement (Cerecor Inc.)", "score": 27.3559207916, "published": true}], "size": 11, "hash": "129a612ff7064a047f54e665fc2c9549", "id": 1}, {"snippet": "Seller Parties, their Affiliates or any of their respective employees [***] agents or other Third Parties acting on behalf of Seller Parties or any of their Affiliates, are, with respect to the Transferred Assets or the Development, Manufacturing or Commercialization of the Lead Compound and the Additional Compound, in material compliance with applicable anticorruption Law, including the Foreign Corrupt Practices Act of 1977 (the \u201cFCPA\u201d). No Seller Party have received any written notice alleging a material violation of any anticorruption Law, including the FCPA, and to the Knowledge of Seller Parties, no claim has been filed and no investigation is pending or ongoing with respect to any violation of any applicable anticorruption Law, including the FCPA, relating to the Transferred Assets or the Development, Manufacturing or Commercialization of the Lead Compound and the Additional Compound.", "snippet_links": [{"key": "other-third-parties", "type": "definition", "offset": [86, 105]}, {"key": "on-behalf-of", "type": "clause", "offset": [113, 125]}, {"key": "with-respect-to", "type": "clause", "offset": [174, 189]}, {"key": "transferred-assets", "type": "clause", "offset": [194, 212]}, {"key": "the-development", "type": "clause", "offset": [216, 231]}, {"key": "lead-compound", "type": "definition", "offset": [275, 288]}, {"key": "additional-compound", "type": "definition", "offset": [297, 316]}, {"key": "compliance-with-applicable", "type": "clause", "offset": [330, 356]}, {"key": "anticorruption-law", "type": "definition", "offset": [357, 375]}, {"key": "foreign-corrupt-practices-act-of-1977", "type": "clause", "offset": [391, 428]}, {"key": "seller-party", "type": "definition", "offset": [446, 458]}, {"key": "written-notice", "type": "definition", "offset": [477, 491]}, {"key": "material-violation", "type": "clause", "offset": [503, 521]}, {"key": "the-fcpa", "type": "clause", "offset": [559, 567]}, {"key": "knowledge-of-seller-parties", "type": "definition", "offset": [580, 607]}, {"key": "no-claim", "type": "clause", "offset": [609, 617]}, {"key": "no-investigation", "type": "clause", "offset": [637, 653]}, {"key": "relating-to", "type": "definition", "offset": [764, 775]}], "samples": [{"hash": "7pGrxjQLsWU", "uri": "/contracts/7pGrxjQLsWU#anticorruption-matters", "label": "Asset Purchase Agreement (Roivant Sciences Ltd.)", "score": 32.364818573, "published": true}, {"hash": "7U7u8QZrTzV", "uri": "/contracts/7U7u8QZrTzV#anticorruption-matters", "label": "Asset Purchase Agreement", "score": 31.3408622742, "published": true}, {"hash": "13YS9YpYmye", "uri": "/contracts/13YS9YpYmye#anticorruption-matters", "label": "Asset Purchase Agreement (Dermavant Sciences LTD)", "score": 30.3908290863, "published": true}], "size": 4, "hash": "218141120ef2ad9557d1dd2aa765fa3e", "id": 2}, {"snippet": "(a) None of the Acquired Companies nor, to the Company\u2019s Knowledge, any of their respective directors, officers, employees, Representatives or agents (in each case, acting in the capacity of an employee or Representative of any Acquired Company) has directly or indirectly, since January 1, 2017, (i) used or knowingly offered any funds (whether of an Acquired Company or otherwise) for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii) made or knowingly offered to make any unlawful payment to any foreign or domestic government official or employee or any political party or party official or candidate for political office, (iii) made or knowingly offered to make any bribe, rebate, payoff, influence payment, kickback or other unlawful payment, (iv) violated any provision of any Anticorruption Laws or any rules or regulations promulgated thereunder or any anti-money laundering laws or any rules or regulations promulgated thereunder or any Applicable Law of similar or (v) has received any written communication that alleges any of the foregoing, except, in each case, as has not been, and would not reasonably be expected to be, materially adverse to the Acquired Companies, taken as a whole. The Company has instituted and maintains and operates an effective compliance program as well as internal controls, policies and procedures that are designed to prevent and detect violations of Anticorruption Laws, including through a system of internal financial and business controls, in each case in conformance with applicable standards to ensure compliance with Anticorruption Laws.\n(b) None of the Acquired Companies nor, to the Company\u2019s Knowledge, any of their respective directors, officers, employees, Representatives or agents (in each case, acting in the capacity of an employee or Representative of any Acquired Company): (i) is currently nor has been since January 1, 2017 the subject of (A) any action alleging a violation, or possible violation, of any Anticorruption Laws, or (B) the recipient of a subpoena, letter of investigation or other document alleging a violation, or possible violation, of any Anticorruption Law; or (ii) has, since January 1, 2017, improperly or inaccurately recorded in any books and records (A) any payments, cash, contributions, gifts, hospitalities or entertainment to any foreign or domestic government official or employee or any political party or party official or candidate for political office or (B) other expenses related to political activity or lobbying, except, in each case, as has not been, and would not reasonably be expected to be, materially adverse to the Acquired Companies, taken as a whole.", "snippet_links": [{"key": "the-acquired-companies", "type": "clause", "offset": [12, 34]}, {"key": "to-the-company", "type": "clause", "offset": [40, 54]}, {"key": "each-case", "type": "definition", "offset": [154, 163]}, {"key": "an-employee", "type": "definition", "offset": [191, 202]}, {"key": "acquired-company", "type": "definition", "offset": [228, 244]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [250, 272]}, {"key": "unlawful-contributions", "type": "clause", "offset": [387, 409]}, {"key": "relating-to", "type": "definition", "offset": [459, 470]}, {"key": "political-activity", "type": "definition", "offset": [471, 489]}, {"key": "payment-to", "type": "clause", "offset": [543, 553]}, {"key": "official-or-employee", "type": "definition", "offset": [589, 609]}, {"key": "political-party", "type": "definition", "offset": [617, 632]}, {"key": "party-official", "type": "definition", "offset": [636, 650]}, {"key": "political-office", "type": "clause", "offset": [668, 684]}, {"key": "provision-of", "type": "clause", "offset": [826, 838]}, {"key": "rules-or-regulations", "type": "clause", "offset": [870, 890]}, {"key": "money-laundering-laws", "type": "definition", "offset": [926, 947]}, {"key": "applicable-law", "type": "clause", "offset": [1006, 1020]}, {"key": "written-communication", "type": "definition", "offset": [1056, 1077]}, {"key": "the-foregoing", "type": "clause", "offset": [1098, 1111]}, {"key": "materially-adverse", "type": "definition", "offset": [1196, 1214]}, {"key": "taken-as-a-whole", "type": "clause", "offset": [1242, 1258]}, {"key": "the-company-has", "type": "clause", "offset": [1260, 1275]}, {"key": "effective-compliance-program", "type": "definition", "offset": [1317, 1345]}, {"key": "internal-controls", "type": "clause", "offset": [1357, 1374]}, {"key": "policies-and-procedures", "type": "definition", "offset": [1376, 1399]}, {"key": "financial-and-business", "type": "clause", "offset": [1514, 1536]}, {"key": "applicable-standards", "type": "definition", "offset": [1580, 1600]}, {"key": "compliance-with-anticorruption-laws", "type": "clause", "offset": [1611, 1646]}, {"key": "subject-of", "type": "clause", "offset": [1951, 1961]}, {"key": "any-action", "type": "definition", "offset": [1966, 1976]}, {"key": "possible-violation", "type": "clause", "offset": [2002, 2020]}, {"key": "the-recipient", "type": "clause", "offset": [2057, 2070]}, {"key": "letter-of", "type": "definition", "offset": [2086, 2095]}, {"key": "other-document", "type": "definition", "offset": [2113, 2127]}, {"key": "books-and-records", "type": "clause", "offset": [2279, 2296]}, {"key": "other-expenses", "type": "clause", "offset": [2515, 2529]}, {"key": "related-to", "type": "clause", "offset": [2530, 2540]}], "samples": [{"hash": "j8pQljbt1f6", "uri": "/contracts/j8pQljbt1f6#anticorruption-matters", "label": "Agreement and Plan of Merger (Alexion Pharmaceuticals, Inc.)", "score": 29.3463382721, "published": true}, {"hash": "dnWlXRIjspP", "uri": "/contracts/dnWlXRIjspP#anticorruption-matters", "label": "Merger Agreement (Portola Pharmaceuticals Inc)", "score": 29.3463382721, "published": true}], "size": 4, "hash": "c08766f0917bf8f45c6366f8b291d7b0", "id": 3}, {"snippet": "(a) The Company Group has not and, to the Company\u2019s Knowledge, none of the Company Group\u2019s agents, consultants, distributors, joint venture partners or other Persons acting on behalf of the Company Group, has violated the Anticorruption Laws.\n(b) To the Company\u2019s Knowledge, no payment has been made by the Company Group in violation of Anticorruption Laws.\n(c) To the Company\u2019s Knowledge, (i) there is no investigation of, or request for information from, the Company Group by any Governmental Authority regarding Anticorruption Laws or (ii) any other allegation, investigation or inquiry regarding the Company Group\u2019s actual or possible violation of Anticorruption Laws.\n(d) None of the current officers, directors or employees of the Company or any of the Company Subsidiaries is a Government Official.\n(e) The Company Group has established, implemented and continues to maintain reasonable internal controls and procedures intended to ensure compliance with Anticorruption Laws, including controls and procedures designed to ensure that the employees and agents of, and all other Persons who perform or have performed services for or on behalf of, the Company or any of the Company Subsidiaries do not make payments in violation of Anticorruption Laws.\n(f) No director or officer of the Company or any of the Company Subsidiaries has, directly or indirectly, made false or misleading statements to, or attempted to coerce or fraudulently influence, an accountant in connection with any audit, review, or examination of the financial statements of the Company or any of the Company Subsidiaries.", "snippet_links": [{"key": "the-company-group", "type": "definition", "offset": [4, 21]}, {"key": "to-the-company", "type": "clause", "offset": [35, 49]}, {"key": "joint-venture-partners", "type": "definition", "offset": [126, 148]}, {"key": "other-persons", "type": "definition", "offset": [152, 165]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [176, 197]}, {"key": "has-violated", "type": "definition", "offset": [205, 217]}, {"key": "no-payment", "type": "clause", "offset": [275, 285]}, {"key": "by-the-company", "type": "clause", "offset": [300, 314]}, {"key": "in-violation", "type": "definition", "offset": [321, 333]}, {"key": "no-investigation", "type": "clause", "offset": [403, 419]}, {"key": "information-from", "type": "clause", "offset": [439, 455]}, {"key": "group-by", "type": "clause", "offset": [469, 477]}, {"key": "governmental-authority", "type": "definition", "offset": [482, 504]}, {"key": "regarding-the-company", "type": "clause", "offset": [590, 611]}, {"key": "possible-violation", "type": "clause", "offset": [630, 648]}, {"key": "current-officers", "type": "definition", "offset": [689, 705]}, {"key": "employees-of-the-company", "type": "clause", "offset": [720, 744]}, {"key": "the-company-subsidiaries", "type": "clause", "offset": [755, 779]}, {"key": "government-official", "type": "definition", "offset": [785, 804]}, {"key": "to-maintain", "type": "clause", "offset": [871, 882]}, {"key": "internal-controls-and-procedures", "type": "clause", "offset": [894, 926]}, {"key": "compliance-with-anticorruption-laws", "type": "clause", "offset": [946, 981]}, {"key": "employees-and-agents", "type": "definition", "offset": [1045, 1065]}, {"key": "services-for", "type": "clause", "offset": [1122, 1134]}, {"key": "payments-in", "type": "clause", "offset": [1211, 1222]}, {"key": "officer-of-the-company", "type": "definition", "offset": [1276, 1298]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [1339, 1361]}, {"key": "false-or-misleading-statements", "type": "clause", "offset": [1368, 1398]}, {"key": "in-connection-with", "type": "clause", "offset": [1467, 1485]}, {"key": "financial-statements-of-the-company", "type": "definition", "offset": [1527, 1562]}], "samples": [{"hash": "7x9brGIYBe4", "uri": "/contracts/7x9brGIYBe4#anticorruption-matters", "label": "Merger Agreement (Open Text Corp)", "score": 25.9253940582, "published": true}, {"hash": "43OuELJARZV", "uri": "/contracts/43OuELJARZV#anticorruption-matters", "label": "Merger Agreement (Actuate Corp)", "score": 25.9253940582, "published": true}], "size": 3, "hash": "e29e2faaa2c9247c0316ca379ad427e2", "id": 4}, {"snippet": "(a) The Company has not and, to the Company\u2019s Knowledge, none of the Acquired Companies\u2019 agents, consultants, distributors, joint venture partners or other Persons authorized to act on behalf of the Acquired Companies, has taken, directly or indirectly, any action or refrained from taking any action that would cause (i) any Acquired Company or, (ii) as of and following the Closing Date, Parent and Merger Sub to be in violation of the Anticorruption Laws.\n(b) The Company Group has not and, to the Company\u2019s Knowledge, none of the Company Group\u2019s agents, consultants, distributors, joint venture partners or other Persons authorized to act on behalf of the Company Group, has taken any act in furtherance of an offer, payment, promise to pay, authorization or ratification of the payment, directly or indirectly, of any gift, money or anything of value to a Governmental Official to obtain or retain business or to secure any improper advantage, including to obtain a Tax rate lower than allowed by applicable Law.\n(c) The Acquired Companies have established and continue to maintain reasonable internal controls and procedures intended to ensure compliance with the Anticorruption Laws.", "snippet_links": [{"key": "the-company-has", "type": "clause", "offset": [4, 19]}, {"key": "to-the-company", "type": "clause", "offset": [29, 43]}, {"key": "the-acquired-companies", "type": "clause", "offset": [65, 87]}, {"key": "joint-venture-partners", "type": "definition", "offset": [124, 146]}, {"key": "persons-authorized-to-act", "type": "clause", "offset": [156, 181]}, {"key": "on-behalf-of", "type": "clause", "offset": [182, 194]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [230, 252]}, {"key": "any-action", "type": "definition", "offset": [254, 264]}, {"key": "acquired-company", "type": "definition", "offset": [326, 342]}, {"key": "following-the-closing-date", "type": "clause", "offset": [362, 388]}, {"key": "parent-and-merger-sub", "type": "clause", "offset": [390, 411]}, {"key": "violation-of-the", "type": "clause", "offset": [421, 437]}, {"key": "anticorruption-laws", "type": "definition", "offset": [438, 457]}, {"key": "the-company-group", "type": "definition", "offset": [463, 480]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [646, 667]}, {"key": "promise-to-pay", "type": "definition", "offset": [730, 744]}, {"key": "ratification-of", "type": "clause", "offset": [763, 778]}, {"key": "the-payment", "type": "clause", "offset": [779, 790]}, {"key": "anything-of-value", "type": "clause", "offset": [838, 855]}, {"key": "governmental-official", "type": "definition", "offset": [861, 882]}, {"key": "to-secure", "type": "clause", "offset": [915, 924]}, {"key": "improper-advantage", "type": "definition", "offset": [929, 947]}, {"key": "tax-rate", "type": "clause", "offset": [971, 979]}, {"key": "applicable-law", "type": "clause", "offset": [1002, 1016]}, {"key": "to-maintain", "type": "clause", "offset": [1075, 1086]}, {"key": "internal-controls-and-procedures", "type": "clause", "offset": [1098, 1130]}, {"key": "compliance-with-the", "type": "clause", "offset": [1150, 1169]}], "samples": [{"hash": "f1TEmIZrTSo", "uri": "/contracts/f1TEmIZrTSo#anticorruption-matters", "label": "Merger Agreement (GXS Worldwide, Inc.)", "score": 24.8494186401, "published": true}, {"hash": "8SsmP9xpJvm", "uri": "/contracts/8SsmP9xpJvm#anticorruption-matters", "label": "Merger Agreement (Open Text Corp)", "score": 24.8466796875, "published": true}], "size": 2, "hash": "fba4126127ba1fd6b16e66c0fe9f8f08", "id": 5}, {"snippet": "Neither the Company nor, to the Company\u2019s Knowledge, any of its officers, employees, representatives or agents (in each case, acting in the capacity of an employee or representative of the Company) has directly or indirectly (i) used any funds (whether of the Company or otherwise) for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to foreign or domestic political parties or campaigns or accepted such payment or (iii) violated any provision of any Anticorruption Laws or any rules or regulations promulgated thereunder or any anti-money laundering laws or any rules or regulations promulgated thereunder or any Applicable Law of similar effect, except, in each case, as would not have, and would not reasonably be expected to have a Company Material Adverse Effect. Between September 30, 2015 and the date of this Agreement, the Company has not received any written communication that alleges any of the foregoing, except as would not have, and would not reasonably be expected, to have a Company Material Adverse Effect.", "snippet_links": [{"key": "neither-the-company", "type": "definition", "offset": [0, 19]}, {"key": "to-the-company", "type": "clause", "offset": [25, 39]}, {"key": "each-case", "type": "definition", "offset": [115, 124]}, {"key": "an-employee", "type": "definition", "offset": [152, 163]}, {"key": "representative-of-the-company", "type": "definition", "offset": [167, 196]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [202, 224]}, {"key": "unlawful-contributions", "type": "clause", "offset": [286, 308]}, {"key": "relating-to", "type": "definition", "offset": [358, 369]}, {"key": "political-activity", "type": "definition", "offset": [370, 388]}, {"key": "payment-to", "type": "clause", "offset": [413, 423]}, {"key": "government-officials", "type": "clause", "offset": [444, 464]}, {"key": "political-parties", "type": "definition", "offset": [504, 521]}, {"key": "provision-of", "type": "clause", "offset": [582, 594]}, {"key": "anticorruption-laws", "type": "definition", "offset": [599, 618]}, {"key": "rules-or-regulations", "type": "clause", "offset": [626, 646]}, {"key": "money-laundering-laws", "type": "definition", "offset": [682, 703]}, {"key": "applicable-law", "type": "clause", "offset": [762, 776]}, {"key": "company-material-adverse-effect", "type": "clause", "offset": [884, 915]}, {"key": "between-september", "type": "clause", "offset": [917, 934]}, {"key": "date-of-this-agreement", "type": "clause", "offset": [952, 974]}, {"key": "the-company-has", "type": "clause", "offset": [976, 991]}, {"key": "written-communication", "type": "definition", "offset": [1009, 1030]}, {"key": "the-foregoing", "type": "clause", "offset": [1051, 1064]}], "samples": [{"hash": "caKF5L3HHsL", "uri": "/contracts/caKF5L3HHsL#anticorruption-matters", "label": "Merger Agreement (Gurnet Holding Co)", "score": 29.8049278259, "published": true}, {"hash": "j18Smwng9Yt", "uri": "/contracts/j18Smwng9Yt#anticorruption-matters", "label": "Merger Agreement (Corium International, Inc.)", "score": 29.7748126984, "published": true}], "size": 2, "hash": "b1a7b88dc7c318490c2192be536695fe", "id": 6}, {"snippet": "Neither Fortis, nor, [*], any of the Representatives of Fortis has, directly or indirectly, taken any action in the [*] in violation in any material respect of any applicable anticorruption Law, including the U.S. Foreign Corrupt Practices Act (\u201cFCPA\u201d) (15 U.S.C. \u00a7 78 dd-1 et seq.).", "snippet_links": [{"key": "representatives-of", "type": "clause", "offset": [37, 55]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [68, 90]}, {"key": "any-action", "type": "definition", "offset": [98, 108]}, {"key": "in-violation", "type": "definition", "offset": [120, 132]}, {"key": "material-respect", "type": "definition", "offset": [140, 156]}, {"key": "anticorruption-law", "type": "definition", "offset": [175, 193]}, {"key": "the-us", "type": "clause", "offset": [205, 212]}, {"key": "foreign-corrupt-practices-act", "type": "definition", "offset": [214, 243]}], "samples": [{"hash": "ldJJZz6jw2h", "uri": "/contracts/ldJJZz6jw2h#anticorruption-matters", "label": "Option Agreement and Plan of Merger (Fibrogen Inc)", "score": 35.5954818726, "published": true}, {"hash": "93ElqxtvczR", "uri": "/contracts/93ElqxtvczR#anticorruption-matters", "label": "Option Agreement and Plan of Merger (Fibrogen Inc)", "score": 34.5961685181, "published": true}], "size": 2, "hash": "43539e1e303e7fd617f967872a80a217", "id": 7}, {"snippet": "None of GSK, any of its Affiliates or any of their respective employees or, to the Knowledge of GSK, agents or other Third Parties acting on behalf of GSK or any of its Affiliates, in any way relating to GSK or any of its Affiliates with respect to the Assets or the Manufacture or Exploitation of any Compound: (i) has taken any action in violation of any applicable anticorruption Legal Requirement, including the Foreign Corrupt Practices Act of 1977 (the \u201cFCPA\u201d); or (ii) has corruptly offered, paid, given, promised to pay or give, or authorized the payment or gift of anything of value, directly or indirectly, to any Public Official, for purposes of (A) influencing any act or decision of any Public Official in his or her public capacity; (B) inducing such Public Official to do or omit to do any act in violation of his or her lawful duty; (C) securing any improper advantage; or (D) inducing such Public Official to use his or her influence with a Governmental Authority in order to assist GSK or any of its Affiliates or any person or entity in any way to any of them, in obtaining or retaining business with respect to the Assets. To the Knowledge of GSK, there are no pending issues with respect to violation of any applicable anticorruption Legal Requirement, including the FCPA, relating to the Assets or the Manufacture or Exploitation of any Compound.", "snippet_links": [{"key": "knowledge-of", "type": "definition", "offset": [83, 95]}, {"key": "other-third-parties", "type": "definition", "offset": [111, 130]}, {"key": "on-behalf-of", "type": "clause", "offset": [138, 150]}, {"key": "relating-to", "type": "definition", "offset": [192, 203]}, {"key": "with-respect-to", "type": "clause", "offset": [233, 248]}, {"key": "the-assets", "type": "clause", "offset": [249, 259]}, {"key": "any-action", "type": "definition", "offset": [326, 336]}, {"key": "in-violation", "type": "definition", "offset": [337, 349]}, {"key": "legal-requirement", "type": "definition", "offset": [383, 400]}, {"key": "foreign-corrupt-practices-act-of-1977", "type": "clause", "offset": [416, 453]}, {"key": "to-pay", "type": "clause", "offset": [521, 527]}, {"key": "the-payment", "type": "clause", "offset": [551, 562]}, {"key": "anything-of-value", "type": "clause", "offset": [574, 591]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [593, 615]}, {"key": "public-official", "type": "definition", "offset": [624, 639]}, {"key": "for-purposes-of", "type": "clause", "offset": [641, 656]}, {"key": "improper-advantage", "type": "definition", "offset": [866, 884]}, {"key": "governmental-authority", "type": "definition", "offset": [958, 980]}, {"key": "to-assist", "type": "clause", "offset": [990, 999]}, {"key": "person-or-entity", "type": "definition", "offset": [1036, 1052]}, {"key": "pending-issues", "type": "clause", "offset": [1181, 1195]}, {"key": "the-fcpa", "type": "clause", "offset": [1284, 1292]}], "samples": [{"hash": "8R7pA2iE6hP", "uri": "/contracts/8R7pA2iE6hP#anticorruption-matters", "label": "Asset Purchase Agreement (Axovant Sciences Ltd.)", "score": 26.3552360535, "published": true}, {"hash": "eJ3xAFZWMLT", "uri": "/contracts/eJ3xAFZWMLT#anticorruption-matters", "label": "Asset Purchase Agreement (Axovant Sciences Ltd.)", "score": 26.3251190186, "published": true}], "size": 2, "hash": "b3444c7ca6aea52a7149f156a00fe70c", "id": 8}, {"snippet": "Within the past five (5) years, the Company Group has not violated and, to the Company\u2019s Knowledge, none of the Company Group\u2019s agents or other Persons acting on behalf of the Company have violated the Anticorruption Laws. The Company and each Company Subsidiary has instituted and maintains policies, procedures and internal controls reasonably designed to ensure compliance with all applicable Anticorruption Laws.\n(a) To the Company\u2019s Knowledge, (i) there is no pending investigation of or outstanding request for information from the Company Group by any Governmental Authority regarding Anticorruption Laws and (ii) there is not pending any other allegation, investigation or inquiry regarding the Company Group\u2019s actual or possible violation of Anticorruption Laws.\n(b) None of the current officers, directors or, to the Company\u2019s Knowledge, employees of the Company or any of the Company Subsidiaries is a Government Official.", "snippet_links": [{"key": "the-company-group", "type": "definition", "offset": [32, 49]}, {"key": "to-the-company", "type": "clause", "offset": [72, 86]}, {"key": "other-persons", "type": "definition", "offset": [138, 151]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [162, 183]}, {"key": "company-subsidiary", "type": "definition", "offset": [244, 262]}, {"key": "internal-controls", "type": "clause", "offset": [317, 334]}, {"key": "compliance-with", "type": "definition", "offset": [365, 380]}, {"key": "applicable-anticorruption-laws", "type": "definition", "offset": [385, 415]}, {"key": "no-pending-investigation", "type": "clause", "offset": [462, 486]}, {"key": "information-from-the-company", "type": "clause", "offset": [517, 545]}, {"key": "group-by", "type": "clause", "offset": [546, 554]}, {"key": "governmental-authority", "type": "definition", "offset": [559, 581]}, {"key": "regarding-the-company", "type": "clause", "offset": [689, 710]}, {"key": "possible-violation", "type": "clause", "offset": [729, 747]}, {"key": "current-officers", "type": "definition", "offset": [788, 804]}, {"key": "employees-of-the-company", "type": "clause", "offset": [848, 872]}, {"key": "the-company-subsidiaries", "type": "clause", "offset": [883, 907]}, {"key": "government-official", "type": "definition", "offset": [913, 932]}], "samples": [{"hash": "kxBAH5WTV3w", "uri": "/contracts/kxBAH5WTV3w#anticorruption-matters", "label": "Merger Agreement (Constant Contact, Inc.)", "score": 26.8343601227, "published": true}, {"hash": "clzQkdbemzm", "uri": "/contracts/clzQkdbemzm#anticorruption-matters", "label": "Merger Agreement (Endurance International Group Holdings, Inc.)", "score": 26.8343601227, "published": true}], "size": 2, "hash": "dc94a02fbe5f4d82549cfd72dde0bf06", "id": 9}, {"snippet": "Party B, its subsidiaries and its and their directors and officers, and to Party B\u2019s knowledge, its and their other employees, agents and other representatives (in each case, acting in their capacities as such) is in compliance with the U.S. Foreign Corrupt Practices Act of 1977, as amended, and all other similar applicable foreign and domestic anticorruption or antibribery laws. \u53cd\u8150\u8d25\u4e8b\u9879\u3002\u4e59\u65b9\u3001\u5176\u5b50\u516c\u53f8\u4ee5\u53ca\u5176\u53ca\u5b50\u516c\u53f8\u7684\u8463\u4e8b\u3001\u9ad8\u7ba1\u3001\u4ee5\u53ca\u636e\u4e59\u65b9\u6240\u77e5\u4e59\u65b9\u53ca\u5176\u5b50\u516c\u53f8\u7684\u5176\u4ed6\u96c7\u5458\u3001\u4ee3\u7406\u6216\u5176\u4ed6\u4ee3\u8868\uff08\u6bcf\u79cd\u60c5\u5f62\u4e2d\u4ee5\u5176\u81ea\u8eab\u540d\u4e49\u884c\u4e8b\uff09\u5747\u7b26\u5408\u7f8e\u56fd1977\u5e74\u300a\u53cd\u6d77\u5916\u8150\u8d25\u6cd5\u300b\u53ca\u5176\u4e0d\u65f6\u8fdb\u884c\u7684\u4fee\u8ba2\u548c\u6240\u6709\u5176\u4ed6\u7c7b\u4f3c\u7684\u9002\u7528\u7684\u6d77\u5916\u548c\u56fd\u5185\u53cd\u8150\u8d25\u6216\u53cd\u8d3f\u8d42\u6cd5\u5f8b\u3002", "snippet_links": [{"key": "party-b", "type": "definition", "offset": [0, 7]}, {"key": "directors-and-officers", "type": "definition", "offset": [44, 66]}, {"key": "other-employees", "type": "clause", "offset": [110, 125]}, {"key": "other-representatives", "type": "definition", "offset": [138, 159]}, {"key": "each-case", "type": "definition", "offset": [164, 173]}, {"key": "the-us", "type": "clause", "offset": [233, 240]}, {"key": "foreign-corrupt-practices-act-of-1977", "type": "clause", "offset": [242, 279]}, {"key": "as-amended", "type": "definition", "offset": [281, 291]}], "samples": [{"hash": "7yP8gHCoMKn", "uri": "/contracts/7yP8gHCoMKn#anticorruption-matters", "label": "Agreement for Assets Purchase by Share Issue (Grifols SA)", "score": 30.2566738129, "published": true}], "size": 2, "hash": "ac1781b6477e4ad95ec1ea9402fb34fe", "id": 10}], "next_curs": "Cl8SWWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjsLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2Ih9hbnRpY29ycnVwdGlvbi1tYXR0ZXJzIzAwMDAwMDBhDKIBAmVuGAAgAA==", "clause": {"title": "Anticorruption Matters", "children": [], "parents": [["representations-and-warranties-of-the-company", "REPRESENTATIONS AND WARRANTIES OF THE COMPANY"], ["representations-and-warranties-of-seller", "REPRESENTATIONS AND WARRANTIES OF SELLER"], ["representations-and-warranties-of-seller-parties", "REPRESENTATIONS AND WARRANTIES OF SELLER PARTIES"], ["representations-and-warranties", "Representations and Warranties"], ["representations-and-warranties-of-sellers", "REPRESENTATIONS AND WARRANTIES OF SELLERS"]], "size": 49, "id": "anticorruption-matters", "related": [["anticorruption", "Anticorruption", "Anticorruption"], ["anti-corruption-and-anti-bribery-laws", "Anti-Corruption and Anti-Bribery Laws", "Anti-Corruption and Anti-Bribery Laws"], ["governance-and-anticorruption", "Governance and Anticorruption", "Governance and Anticorruption"], ["anti-corruption-laws-and-sanctions", "Anti-Corruption Laws and Sanctions", "Anti-Corruption Laws and Sanctions"], ["anti-corruption-laws-sanctions", "Anti-Corruption Laws; Sanctions", "Anti-Corruption Laws; Sanctions"]], "related_snippets": [], "updated": "2026-02-25T05:25:33+00:00"}, "json": true, "cursor": ""}}